BRKR

#864
Bruker Corporation - Common Stock
58.8 9 USD
+8.31%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
58.89
58.90
Range Annuel
28.53
58.90
Changement quotidien
+8.31%
Changement Mensuel
+69.86%
Evolution sur 6 mois
+21.12%
Changement Annuel
+60.51%
Clôture Précédente
54.3 7
Open
58.9 0
Low
58.8 9
High
58.9 0
Volume
263
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
  • Market Capitalization 8.96 B
  • Employee 11 K
  • Founded N/A
  • CEO Frank Laukien
  • Website www.bruker.com
  • Headquarter Delaware, United States
  • FIGI BBG000CL1FG7
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-314.07
ratio cours/chiffre d'affaires
2.08
Dividende par action
—
Rendement du dividende (%)
—

Bruker Corporation - Common Stock

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies divisions. In April 2010, Bruker created a Chemical Analysis Division under the Bruker Daltonics subsidiary. This division contains three former Varian product lines: ICPMS systems, laboratory gas chromatography, and GC-triple quadrupole mass spectrometer. In 2012, it sponsored the Fritz Feigl Prize, and since 1999 the company has also sponsored the Günther Laukien Prize.

Nouvelles